Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Pharma – Johnson & Johnson lancera son OPA le 3 mars | Tribune de Genève
Der Actelion-Gründer hat alle seine Ziele erreicht – und beginnt von vorn | NZZ
Vor der Übernahme ein Rekordergebnis | Tages-Anzeiger
How is Actelion Spin-Off Idorsia Doing One Year Later?
PDF) Profile: Jean-Paul Clozel | charlie schmidt - Academia.edu
Actelion Could Boost Takeover Price for Johnson & Johnson
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Johnson & Johnson pays big for Swiss biotech firm Actelion | Euronews
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
Jean-Paul Clozel
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Actelion-Gründer erhalten Preis der Vereinigung Starkes Basel
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
Actelion CEO and founder Jean-Paul Clozel attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Photo Stock - Alamy
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
